Shots:The past few years have shown an accelerated development in the digital therapeutics market through various applications, tracking devices, and telemedicine being integrated into digital therapiesDigital therapeutics provided powerful tools to maintain the public healthcare system during the Covid-19 pandemic for the people to access treatments for both physical & psychological conditions at home…
The diagnostic companies continued to serve the high demand for diagnostic testing throughout the COVID-19 pandemic in 2021Siemens Healthineers, Roche, GE Healthcare, and Abbott were the top players in the race for the global diagnostic companiesPharmaShots has compiled a list of the top 20 diagnostics Companies based on their 2021 revenue in the…
Despite the severe impact of the Covid-19 pandemic in 2020, the medical device market continued to emerge with patients' more significant needs and emerging diseases In 2021, the medical device markets continued to supply personal protective equipment for the pandemic and new technological developments. Medtronic remains at the top of the ledger with total revenue…
While the COVID-19 pandemic has dominated the healthcare space for the last two years, some biopharma companies were involved in multiple deals, M&A, and the development of various drug candidates in other areas to diversify their portfoliosWhile top Biopharma companies remain on the chart, however, in 2021, new players like Moderna, BioNTech, Viatris also…
Shots:The biopharma industry saw numerous deal terminations in 2021. Clinical and regulatory results, change of control limitations, and strategic reprioritizations were among the most common reasons for deal termination.SOBI and Advent's acquisition agreement in 2021 ranked first under which Advent International offered to acquire SOBI. The second position goes to Galapagos’ development and…
Shots:The life science industry saw high deal activity in 2021 staying in the range of an even busier 2020.Fourth-quarter 2021 set the tone with Recursion’s development and commercialization deal with Roche and Genentech for a total value of $12.7B, followed by Poseida Therapeutics’ development and commercialization deal with Takeda for $3.73B.This article is based on the 2021…
Shots:Biopharma merger and acquisition activity continued under the radar with smaller deals through 2021. Despite the absence of eagerly-awaited mega-merger, there were a number of deals above $1 billion.CSL Limited holds the top rank by acquiring Vifor Pharma among the top 20 acquisitions with a total deal value of $11.7B. CSL adds 10…
Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human lifeFor a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes…
Shots:Generic medicines are the backbone of the healthcare system and are identical to the innovator medicine in strength- effect- dosage form- and route of administration. These are allowed for sale after the patent expiry of the original drugsOur team at PharmaShots has compiled a list of the top 20 generic companies based on…
Oncology is a rapidly evolving therapy area and all of the top Biopharma players are investing in the research and development of cancer therapies. In 2020- the world witnessed a major acquisition of Immunomedic by Gilead of $21B for TrodelvyOur team at PharmaShots has compiled a list of top 20 oncology companies based on…

